Orgenesis Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 0.53 million compared to USD 36.03 million a year ago. Revenue was USD 0.53 million compared to USD 36.03 million a year ago.

Net loss was USD 55.36 million compared to USD 14.89 million a year ago. Basic loss per share from continuing operations was USD 1.91 compared to USD 0.59 a year ago. Diluted loss per share from continuing operations was USD 1.91 compared to USD 0.59 a year ago.